About Swift Biosciences
Swift Biosciences is a company based in Ann Arbor (United States) founded in 2010 was acquired by Integrated DNA Technologies in March 2021. Swift Biosciences has raised $35.2 million across 10 funding rounds from investors including Integrated DNA Technologies, Fletcher Spaght and Arboretum Ventures. The company has 41 employees as of December 31, 2022. Swift Biosciences operates in a competitive market with competitors including Abcam, Neogen, Sino Biological, GenScript and LGC, among others.
- Headquarter Ann Arbor, United States
- Employees 41 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Swift Biosciences, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$35.2 M (USD)
in 10 rounds
-
Latest Funding Round
$4 M (USD), Series D
Nov 01, 2018
-
Investors
Integrated DNA Technologies
& 5 more
-
Employee Count
41
as on Dec 31, 2022
-
Acquired by
Integrated DNA Technologies
(Mar 11, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Swift Biosciences
Unlock access to complete
Software Development Team
75 people
Sales and Marketing
46 people
Product Management Team
36 people
Leadership Team
17 people
Manager Team
14 people
Human Resources and Administration
13 people
Senior Team
10 people
NGS Team
8 people
Unlock access to complete
Funding Insights of Swift Biosciences
Swift Biosciences has successfully raised a total of $35.2M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $4 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Swift Biosciences
Swift Biosciences has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Integrated DNA Technologies, Fletcher Spaght and Arboretum Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Locked | Locked | Locked | |
|
Early-stage investments are directed toward US, India, and Canada firms.
|
Locked | Locked | Locked | |
|
Management consulting and business management services are provided.
|
Locked | Locked | Locked |
Investor details for Swift Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Swift Biosciences
Investment portfolio details for Swift Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Swift Biosciences
Detailed financials for Swift Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Swift Biosciences Comparisons
Peer comparison for Swift Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Swift Biosciences
Swift Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Neogen, Sino Biological, GenScript and LGC, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Molecular biology reagents and services are supplied to biotech industries.
|
|
| Locked | Locked | Locked |
Developer of technologies for the analysis of rare and single cells in the blood
|
Detailed competitors of Swift Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Swift Biosciences
Complete news archive for Swift Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Swift Biosciences
Swift Biosciences was founded in 2010.
Swift Biosciences is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Swift Biosciences is a funded company, having raised a total of $35.2M across 10 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Swift Biosciences is 41.
Swift Biosciences was founded in 2010 and is based in Ann Arbor, United States. Technologies for sample and library preparation in next-generation sequencing are developed by the company within the biotechnology sector. Products such as Accel-NGS DNA library kits for Illumina and Ion Torrent platforms, Accel-Amplicon Panels for mutation screening, and myT Primers for qPCR-based cancer detection are offered to support genetic testing operations.
Swift Biosciences's top competitors include Abcam, Neogen and Sino Biological.
Swift Biosciences has 6 investors. Key investors include Integrated DNA Technologies, Fletcher Spaght, Arboretum Ventures, Renaissance Venture Capital Fund, and Mercury Fund.